Egypt Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Egypt Pharmaceuticals and Healthcare Report

Egypt Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Egypt Pharmaceuticals and Healthcare Report
Published Aug 13, 2016
94 pages — Published Aug 13, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In May ----, Egyptian health minister Ahmed Rady announced a -- price rise for all Egyptian medicines priced up to EGP-- (USD-.--) -including a large proportion of generic medicines. ...-including a large proportion of generic medicines. A new proposal for advancing public health in Egypt, with a focus on four main outcomes was put forward in ----: Human capital development, reforming the national health insurance scheme, reducing the hepatitis C burden, and improving public healthcare facilities. Egypt s evolving demographic and epidemiological profile will support pharmaceutical growth over the long-term. ...Plans to promote science in the country open opportunities for contract research organisations and clinical trial outsourcing. A much needed entrance by an active pharmaceutical ingredients manufacturer would cut the import bill significantly and allow the domestic drugmakers to thrive and, ultimately, boost economic growth in this sector.

...Strict pricing controls and reference pricing system reduces innovative drugmaker profits. Per-capita drug spending in Egypt is among the lowest in the Middle East. ...Patent laws remain notably below international standards, with data protection and enforcement being major concerns. The market is reliant on imports of high-tech products, as well as of raw materials, and thus vulnerable to currency fluctuations resulting in medicine shortages. High proportion of counterfeit drugs in the market. ...The market is reliant on imports of high-tech products, as well as of raw materials, and thus vulnerable to currency fluctuations resulting in medicine shortages. High proportion of counterfeit drugs in the market.

...Egypt presents a moderately attractive commercial opportunity for multinational pharmaceutical companies. Egypt s medium-term growth is positive and has improved significantly over the past year in line with an improving political situation, albeit with persisting instabilities. ...

  
Source:
Document ID
1748-1864
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Egypt Pharmaceuticals and Healthcare Report" Aug 13, 2016. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Egypt-Pharmaceuticals-and-Healthcare-Report-2026-540>
  
APA:
Business Monitor International - Industry Reports. (2016). Egypt Pharmaceuticals and Healthcare Report Aug 13, 2016. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Egypt-Pharmaceuticals-and-Healthcare-Report-2026-540>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.